James Wan and Jason Blum have put a new name over their combined horror operation without retiring the identities that built it.
Blumhouse Atomic is the newly unveiled umbrella title for Blumhouse and Atomic Monster, which merged in 2024. The two companies will continue as separate production labels, with their respective creative teams developing and producing film and television projects under each banner.
That structure gives the merged business a unified identity while allowing Blumhouse and Atomic Monster to retain distinct creative operations.
“Blumhouse Atomic is a natural evolution of what we’ve built together,” Blum, co-founder of Blumhouse Atomic, said. “When we merged our companies, we believed the whole would be greater than the sum of its parts and that is exactly what has happened.”
A horror operation with studio-sized output
The Blumhouse Atomic name arrives after a commercially significant period for the combined banners. Since the merger, their projects have generated more than $2.5 billion at the worldwide box office against combined production budgets totaling less than $330 million.
In 2026 alone, Blumhouse Atomic brought in $1.3 billion. That result was powered in part by two of the year’s biggest hits: Curry Barker’s “Obsession,” which earned $520 million worldwide, and Kane Parsons’ “Backrooms,” which reached $400 million globally.
Blum said the combined operation now has “the output of a studio with the creative freedom and financial discipline of an independent company.” He also pointed to opportunities to expand properties beyond movie theaters and into television, games and live experiences.
The executive cited “The Conjuring” franchise, “Insidious” and “Saw” while discussing Wan’s record of creating horror franchises. Blum also said that bringing “Saw” back to Wan, with a new chapter in development, demonstrates what the companies can accomplish together.
New filmmakers remain central to the strategy
Wan framed Blumhouse Atomic’s next phase around discovering and supporting emerging talent rather than simply consolidating established properties.
“The future of horror comes from new voices, and Blumhouse Atomic gives us more ways to find them and support them for the long haul,” Wan, a co-founder of the company, said.
Wan added that creating such opportunities is personal to him because his own start came through a small film and people willing to take a chance on it. He named Kane Parsons, Curry Barker, Josh Giuliano and Dylan Clark among the filmmakers with whom the company is working.
“We want to give them the freedom to make something distinctive and build relationships that last beyond one film,” Wan said.
The company has also made specific moves to continue producing genre projects at limited budget levels. Sam Zimmerman was appointed senior vice president of development and acquisitions, with responsibility for developing a slate of genre features budgeted below $5 million.
Blumhouse Atomic also recently entered a first-look agreement with Divide/Conquer to develop high-concept projects at an economical rate.
ShowBiz Take
The key detail in the Blumhouse Atomic announcement is not only the new umbrella name, but what is staying intact. Blumhouse and Atomic Monster are not being collapsed into a single production label. Their teams will continue working under the two existing banners even as Wan and Blum present the overall business through one shared identity.
The financial figures also clarify why the model matters. More than $2.5 billion in worldwide box office from combined budgets below $330 million supports the company’s stated focus on pairing controlled spending with broad commercial potential. The under-$5 million genre initiative and the Divide/Conquer deal show that lower-budget development remains part of the plan even after a $1.3 billion year.
At the same time, the structure brings established properties, a growing filmmaker roster and possible expansion into other forms of entertainment under one organizational roof. Blumhouse Atomic therefore signals consolidation at the top without erasing the production labels or creative teams beneath it.
What Happens Next?
Blumhouse Atomic already has nine films listed for its 2027 slate: “River,” “The Revenge of La Llorona,” “The Exorcist: Martyrs,” “Anything But Ghosts,” “Paranormal Activity,” “Molepeople,” “Blair Witch,” “Sleepover” and “Seasons.”
A new “Saw” chapter is also on the way, although no release date or additional details were provided. Together, those projects will offer the first major test of how the newly named umbrella operates while Blumhouse and Atomic Monster continue to maintain their separate production identities.